Interview With Ibs Mahmood DrugDev CEO On Where The Clinical Research Industry Is Headed

I was fortunate enough to have one of the industry's most innovative CEO's, Ibs Mahmood from Drug Dev come on the show and share his insights in regards to what is happening in the clinical research industry.  We especially dive into issues such as clinical trial site payments, how risk based monitoring is affecting research clinics, and also how big data is allowing for transparent and clear site metrics to be tracked and shared by and amongst sponsors and CRO's.